ERBB2 and neoplasm: Several groups of patients were defined according to tumor stage (tumor stage 2–3 vs tumor stage 1), histological grade (high mSBR grades vs low mSBR grades), HER2 status (HER2+ vs HER2-), and relapse occurrence (recurrent vs non-recurrent patients).